Amsterdam, Netherlands

Avigdor Lev

This inventor holds 1 USPTO granted patent. Top assignee: Medical Enterprises, LLC. Active years: 2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Avigdor Lev. Retrieved from https://idiyas.com/inventor/avigdor-lev-h9339osc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 1.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Avigdor Lev: Innovator in Hyperthermia Treatment

Introduction

Avigdor Lev is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of medical technology, particularly in the treatment of tumors through innovative devices. His work focuses on enhancing therapeutic techniques to improve patient outcomes.

Latest Patents

Avigdor Lev holds a patent for a radiating device designed for hyperthermia treatment. This invention features a flexible three-path catheter equipped with a balloon that houses a sealingly sheathed radiofrequency radiating antenna. The device also includes a shielded power supply cable and thermocouples, all contained within a plastic lining that is surrounded by a flow of liquid. The design allows for the introduction of the catheter into a hollow organ, enabling hyperthermal therapy of tumors through radiation.

Career Highlights

Lev is associated with Medical Enterprises, LLC, where he applies his expertise in medical device innovation. His work has been instrumental in advancing techniques for tumor treatment, showcasing his commitment to improving healthcare solutions.

Collaborations

(Section skipped due to space constraints.)

Conclusion

Avigdor Lev's contributions to medical technology, particularly through his patented radiating device for hyperthermia, highlight his role as an innovator in the field. His work continues to pave the way for advancements in tumor treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…